Table 2 Bivariate correlation analysis between PBCCs expression, vascular tissue expression and serum levels parameters.
PBCCs expression (n = 92) | ||||||
|---|---|---|---|---|---|---|
KL (a.u.) | DNMT1 (a.u.) | DNMT3A (a.u.) | ||||
r | P value | r | P value | r | P value | |
PBCCs expression | ||||||
KL (a.u.) | 1.000 | |||||
DNMT1 (a.u.) | − 0.257* | < 0.05 | 1.000 | |||
DNMT3A (a.u.) | − 0.166 | 0.12 | 0.692* | < 0.0001 | 1.000 | |
NFKB1 (a.u.) | − 0.281* | < 0.01 | 0.580* | < 0.0001 | 0.484* | < 0.0001 |
TNF (a.u.) | − 0.310* | < 0.01 | 0.487* | < 0.0001 | 0.308* | < 0.01 |
IL10 (a.u.) | 0.500* | < 0.0001 | − 0.253* | < 0.05 | − 0.235* | < 0.05 |
TNF/IL10 | − 0.509* | < 0.0001 | 0.397* | < 0.001 | 0.306* | < 0.01 |
Serum levels | ||||||
sKL (pg/mL) | 0.173 | 0.11 | − 0.186 | 0.08 | − 0.041 | 0.70 |
TNFα (pg/mL) | 0.162 | 0.12 | − 0.198 | 0.16 | 0.283* | < 0.01 |
IL10 (pg/mL) | 0.253* | < 0.05 | − 0.403* | < 0.0001 | − 0.155 | 0.14 |
TNFα/IL10 | − 0.186 | 0.08 | 0.334 | < 0.01 | 0.069 | 0.52 |
Vascular tissue expression (n = 92) | ||||||
|---|---|---|---|---|---|---|
TNF (a.u.) | IL10 (a.u.) | TNF/IL10 | ||||
r | P value | r | P value | r | P value | |
PBCCs expression | ||||||
KL (a.u.) | − 0.168 | 0.13 | 0.159 | 0.15 | − 0.337* | < 0.01 |
DNMT1 (a.u.) | 0.353* | < 0.01 | 0.069 | 0.53 | 0.236* | < 0.05 |
DNMT3A (a.u.) | 0.309* | < 0.01 | 0.104 | 0.35 | 0.184 | 0.10 |
NFKB1 (a.u.) | 0.379* | < 0.001 | − 0.006 | 0.95 | 0.302* | < 0.01 |
TNF (a.u.) | 0.275* | < 0.05 | 0.037 | 0.74 | 0.196 | 0.08 |
IL10 (a.u.) | − 0.061 | 0.58 | 0.143 | 0.19 | − 0.270* | < 0.05 |
TNF/IL10 | 0.166 | 0.13 | − 0.125 | 0.26 | 0.311* | < 0.01 |
Serum levels | ||||||
sKL (pg/mL) | − 0.179 | 0.11 | − 0.078 | 0.49 | − 0.070 | 0.54 |
TNFα (pg/mL) | − 0.185 | 0.10 | − 0.021 | 0.85 | − 0.144 | 0.20 |
IL10 (pg/mL) | − 0.244* | < 0.05 | 0.137 | 0.22 | − 0.302* | < 0.01 |
TNFα/IL10 | 0.166 | 0.14 | − 0.137 | 0.22 | 0.233* | < 0.05 |